Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LINAGLIPTIN vs LIPEGFILGRASTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LINAGLIPTIN vs LIPEGFILGRASTIM: Safety Overview

Metric LINAGLIPTIN LIPEGFILGRASTIM
Total FAERS Reports 7,762 425
Deaths Reported 726 41
Death Rate 9.4% 9.6%
Hospitalizations 2,794 248
Average Patient Age 70.2 yrs 56.4 yrs
% Female Patients 51.8% 50.0%
FDA Approval Date Aug 31, 2021 N/A
Manufacturer Novadoz Pharmaceuticals LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A